XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Stock-Based Compensation [Abstract]  
Schedule of Stock Based Compensation Expense

Stock based compensation has been reported within expense line items on the consolidated statement of operations for the three months ended March 31, 2020 and 2021 as shown in the following table (in $000s):

 

 

 

 

 

 

 

 

 

 

    

Three Months Ended

    

 

 

March 31, 

 

 

    

2020

    

2021

 

Research and development

 

$

35

 

$

81

 

General and administrative

 

 

56

 

 

174

 

Stock-based compensation costs before income taxes

 

$

91

 

$

255

 

 

Schedule of Fair Value of the Stock Options Granted

The fair value of the stock options granted is calculated using the Black-Scholes option-pricing model as prescribed by ASC 718 using the following assumptions:

 

 

 

 

 

 

 

 

 

Three Months Ended

 

    

March 31, 2021

Expected term (years)

 

5 – 6

Risk free interest rate

 

0.420% – 0.585%

Volatility

 

99 – 102%

Expected dividend yield over expected term

 

0.00%

Resulting weighted average grant date fair value

 

$6.45

 

Schedule of Share Option Activity

A summary of the share option activity and related information is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

Weighted

    

 

 

 

 

 

 

Weighted

 

Average

 

 

 

 

 

Number of

 

Average

 

Remaining

 

Aggregate

 

 

Options

 

Exercise

 

Contractual

 

Intrinsic

 

 

Outstanding

 

Price Per Share

 

Term (Years)

 

Value ($000)

Options outstanding at December 31, 2020

 

602,683

 

$

11.01

 

9.39

 

$

1,861

Granted

 

73,669

 

$

6.45

 

 —

 

 

 —

Exercised

 

 —

 

 

 —

 

 —

 

 

 —

Cancelled/forfeited

 

 —

 

$

 —

 

 —

 

 

 —

Options outstanding at March 31, 2021

 

676,352

 

$

10.51

 

9.22

 

$

1,553

 

 

 

 

 

 

 

 

 

 

 

Unvested at March 31, 2021

 

564,622

 

$

4.78

 

9.60

 

$

1,458

Vested and exercisable at March 31, 2021

 

111,730

 

$

39.47

 

7.30

 

$

95

 

Schedule of Restricted Stock Units Activity

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

Restricted

 

Grant Date

 

 

Stock Units

 

Value Per Share

Restricted Stock Units outstanding at March 31, 2021

 

16,524

 

$

11.30

 

 

 

 

 

 

Unvested at March 31, 2021

 

16,524

 

$

11.30

Vested and exercisable at March 31, 2021

 

 —

 

$

 —